Y-mAbs Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $76K, a 41.1% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $76K -$53K -41.1% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $101K -$31K -23.5% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $74K -$86K -53.8% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $103K -$36K -25.9% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $129K -$29K -18.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $132K -$100K -43.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $160K -$124K -43.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $139K -$200K -59% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $158K -$70K -30.7% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $232K -$44K -15.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $284K -$47K -14.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $339K -$59K -14.8% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $228K -$268K -54% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $276K -$147K -34.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $331K -$146K -30.6% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $398K -$136K -25.5% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $496K -$117K -19.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $423K -$254K -37.5% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $477K -$219K -31.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $534K Dec 31, 2019 10-K 2021-03-01
Q3 2019 $613K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $677K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $696K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.